Home / Brimonidine / Canada
CA ATC S01EA05 · updated 2 Nov 2026
Brimonidine shortage in Canada
Is there a Brimonidine shortage in Canada?
Yes. As of 2 Nov 2026, 4 Brimonidine products are reported short in Canada, the first since 8 Sep 2026. The company estimate for the return is 6 Nov 2026 (latest 5 Feb 2027). Main reason: increased demand.
Also short in Italy, Austria, Czechia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | BRIMONIDINE P (10 ML) | AA PHARMA INC | 8 Sep 2026 | 6 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP BRIMONIDINE (10) | JAMP PHARMA CORPORATION | 15 Sep 2026 | 5 Feb 2027 | Increased demand Demand increase for the drug |
| CA | BRIMONIDINE (10ml) | STERI-MED PHARMA INC. | 1 Oct 2026 | not given | Increased demand Demand increase for the drug |
| CA | APO-BRIMONIDINE (10 ml) discontinuation | APOTEX INC | not given | not given | Not stated |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.